NCT00076310 2025-06-26
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
M.D. Anderson Cancer Center
Merck KGaA, Darmstadt, Germany
AstraZeneca
AstraZeneca
Ministry of Scientific Research and Information Technology, Poland